Celecoxib
- Product NDC
- 63629-5504
- 11-digit product format
- 636295504
- Labeler code
- 63629
- Product ID
- 63629-5504_7363bc3b-aac5-4c49-a656-1a3330b30350
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Celecoxib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- NDA020998
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2014-12-10
- Marketing end
- 0000-00-00
- Substance
- CELECOXIB
- Active strength
- 100 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63629-5504-1 | 2021-07-01 | C162847 | 48780-1 | 9d75b9d0-8707-f424-e053-dadaa90a57ce | 16739138-117a-4569-9f65-d62546af4560 |
| 63629-5504-2 | 2021-07-01 | C162847 | 48780-1 | 9d75b9d0-8707-f424-e053-dadaa90a57ce | 16739138-117a-4569-9f65-d62546af4560 |
| 63629-5504-3 | 2021-07-01 | C162847 | 48780-1 | 9d75b9d0-8707-f424-e053-dadaa90a57ce | 16739138-117a-4569-9f65-d62546af4560 |
| 63629-5504-4 | 2021-07-01 | C162847 | 48780-1 | 9d75b9d0-8707-f424-e053-dadaa90a57ce | 16739138-117a-4569-9f65-d62546af4560 |
| 63629-5504-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8707-f424-e053-dadaa90a57ce | 16739138-117a-4569-9f65-d62546af4560 |
| 63629-5504-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8707-f424-e053-dadaa90a57ce | 16739138-117a-4569-9f65-d62546af4560 |
| 63629-5504-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8707-f424-e053-dadaa90a57ce | 16739138-117a-4569-9f65-d62546af4560 |
| 63629-5504-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8707-f424-e053-dadaa90a57ce | 16739138-117a-4569-9f65-d62546af4560 |